{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:52:20Z","timestamp":1791975140809,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007038","name":"Lung Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ctrv.2026.103223","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:26:22Z","timestamp":1791473182000},"page":"103223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Artificial intelligence\u2013enabled drug discovery: A growing but largely early-stage clinical pipeline"],"prefix":"10.1016","volume":"151","author":[{"given":"Waqas","family":"Haque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareena","family":"Sai-Palm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iemaan","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Verlingue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Chiara","family":"Garassino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ctrv.2026.103223_bb0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.ctrv.2026.103223_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104009","article-title":"How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons","volume":"29","author":"Jayatunga","year":"2024","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103223_bb0015","article-title":"Artificial intelligence in drug design and discovery: a comprehensive review","volume":"5","author":"Bhat","year":"2026","journal-title":"In Silico Res Biomed."},{"issue":"5","key":"10.1016\/j.ctrv.2026.103223_bb0020","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1021\/acs.jcim.3c01736","article-title":"Computational chemistry in structure-based solute carrier transporter drug design: recent advances and future perspectives","volume":"64","author":"Tu","year":"2024","journal-title":"J Chem Inf Model."},{"key":"10.1016\/j.ctrv.2026.103223_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biosystems.2022.104790","article-title":"Adversarial deep evolutionary learning for drug design","volume":"222","author":"Abouchekeir","year":"2022","journal-title":"Biosystems"},{"issue":"9","key":"10.1016\/j.ctrv.2026.103223_bb0030","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"46","key":"10.1016\/j.ctrv.2026.103223_bb0035","doi-asserted-by":"crossref","first-page":"31357","DOI":"10.1021\/jacs.4c11686","article-title":"Deep Lead optimization: leveraging generative AI for structural modification","volume":"146","author":"Zhang","year":"2024","journal-title":"J Am Chem Soc"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103223_bb0040","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae275","article-title":"Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides","volume":"25","author":"Goles","year":"2024","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.ctrv.2026.103223_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102769","article-title":"Generative AI for graph-based drug design: recent advances and the way forward","volume":"84","author":"Garg","year":"2024","journal-title":"Curr Opin Struct Biol"},{"issue":"6781","key":"10.1016\/j.ctrv.2026.103223_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/science.ads9530","article-title":"Deep contrastive learning enables genome-wide virtual screening","volume":"391","author":"Jia","year":"2026","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103223_bb0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s42977-020-00025-5","article-title":"Pharmaceutical drug development: high drug prices and the hidden role of public funding","volume":"72","author":"Annett","year":"2021","journal-title":"Biol Futur"},{"issue":"40","key":"10.1016\/j.ctrv.2026.103223_bb0060","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1093\/eurheartj\/ehae519","article-title":"Clinical trials in-a-dish for cardiovascular medicine","volume":"45","author":"Wu","year":"2024","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103223_bb0065","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/cpt.3152","article-title":"Current status and future directions: the application of artificial intelligence\/machine learning for precision medicine","volume":"115","author":"Naik","year":"2024","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.ctrv.2026.103223_bb0070","article-title":"Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103223_bb0075","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol Divers"},{"key":"10.1016\/j.ctrv.2026.103223_bb0080","unstructured":"FDA announces plan to phase out animal testing requirement for monoclonal antibodies and other drugs (2026)."},{"key":"10.1016\/j.ctrv.2026.103223_bb0085","series-title":"Pharmaprojects and Trialtrove databases","author":"Citeline","year":"2026"},{"key":"10.1016\/j.ctrv.2026.103223_bb0090","unstructured":"ClinicalTrials.gov. 2025."},{"issue":"2","key":"10.1016\/j.ctrv.2026.103223_bb0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","article-title":"Estimation of clinical trial success rates and related parameters","volume":"20","author":"Wong","year":"2019","journal-title":"Biostatistics"},{"key":"10.1016\/j.ctrv.2026.103223_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/20420986251321704","article-title":"Artificial intelligence in drug development: reshaping the therapeutic landscape","volume":"16","author":"Niazi","year":"2025","journal-title":"Ther Adv Drug Saf"},{"issue":"9","key":"10.1016\/j.ctrv.2026.103223_bb0105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/d41573-024-00068-6","article-title":"Efficiency, effectiveness and productivity in pharmaceutical R&D","volume":"23","author":"Roland","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ctrv.2026.103223_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcpo.2024.100503","article-title":"Artificial intelligence and cancer: profile of registered clinical trials","volume":"42","author":"de Oliveira Avellar","year":"2024","journal-title":"J Cancer Policy"},{"issue":"17","key":"10.1016\/j.ctrv.2026.103223_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202200128","article-title":"The impact of AlphaFold protein structure database on the fields of life sciences","volume":"23","author":"Varadi","year":"2023","journal-title":"Proteomics"},{"issue":"13","key":"10.1016\/j.ctrv.2026.103223_bb0120","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1021\/acs.jcim.2c00026","article-title":"AI-based protein structure prediction in drug discovery: impacts and challenges","volume":"62","author":"Schauperl","year":"2022","journal-title":"J Chem Inf Model"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103223_bb0125","article-title":"Artificial intelligence in cancer target identification and drug discovery","volume":"7","author":"You","year":"2022","journal-title":"Signal Transduct Target Ther."},{"issue":"9","key":"10.1016\/j.ctrv.2026.103223_bb0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tips.2023.06.010","article-title":"AI-powered therapeutic target discovery","volume":"44","author":"Pun","year":"2023","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"10.1016\/j.ctrv.2026.103223_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092325","article-title":"Trends and perspectives of biological drug approvals by the FDA: a review from 2015 to 2021","volume":"10","author":"Martins","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103223_bb0140","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2019.1703531","article-title":"Antibodies to watch in 2020","volume":"12","author":"Kaplon","year":"2020","journal-title":"MAbs"},{"key":"10.1016\/j.ctrv.2026.103223_bb0145","series-title":"Nature","author":"A. M. AI deals show no sign of slowing","year":"2026"},{"issue":"9","key":"10.1016\/j.ctrv.2026.103223_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111717","article-title":"Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer\u2019s disease","volume":"41","author":"Xu","year":"2022","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.ctrv.2026.103223_bb0155","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/17460441.2021.1883585","article-title":"Artificial intelligence, machine learning, and drug repurposing in cancer","volume":"16","author":"Tanoli","year":"2021","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.ctrv.2026.103223_bb0160","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semcancer.2019.12.011","article-title":"Machine and deep learning approaches for cancer drug repurposing","volume":"68","author":"Issa","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ctrv.2026.103223_bb0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/bs.pmbts.2024.03.030","article-title":"Application of artificial intelligence and machine learning in drug repurposing","volume":"205","author":"Ghandikota","year":"2024","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103223_bb0170","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41587-026-03039-x","article-title":"Patents on AI-derived drugs: empirical evidence and legal challenges","volume":"44","author":"Freilich","year":"2026","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103223_bb0175","doi-asserted-by":"crossref","first-page":"155","DOI":"10.14573\/altex.2112202","article-title":"Cross-industrial applications of organotypic models","volume":"39","author":"Kopanska","year":"2022","journal-title":"ALTEX"},{"key":"10.1016\/j.ctrv.2026.103223_bb0180","unstructured":"Medicine PCfR. FDA approves new cancer drug for clinical trials based on nonanimal data online. Accessed 02\/24\/2026, 2026."},{"issue":"6","key":"10.1016\/j.ctrv.2026.103223_bb0185","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.15445","article-title":"Costs of drug development and research and development intensity in the US, 2000\u20132018","volume":"7","author":"Sertkaya","year":"2024","journal-title":"JAMA Netw Open."}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226001374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226001374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:26:42Z","timestamp":1791973602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737226001374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"alternative-id":["S0305737226001374"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103223","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence\u2013enabled drug discovery: A growing but largely early-stage clinical pipeline","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103223"}}